NASDAQ · Financial Statements
Histogen Inc. (HSTO) Financial Statements
$0.02
NASDAQ: HSTO
Market Cap $85435
Overview Financials Dividend Histogen Inc. most recently reported annual revenue of $4.0M, a net loss of $11.0M. Revenue declined at an average annual rate of 35.2% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $34.0M $11.0M $2.0M $1.0M $4.0M Operating Profit $-18.0M $-12.0M $-12.0M $-15.0M $-11.0M Net Profit $-18.0M $-11.0M $-19.0M $-15.0M $-11.0M EPS $-118.60 $-5.02 $-41.60 $-7.51 $-3.46 Op Margin -54.4% -104.8% -568.9% -1681.9% -282.4%
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $49.0M $3.0M $15.0M $27.0M $19.0M Total Liabilities $21.0M $41.0M $8.0M $7.0M $6.0M Cash $12.0M $2.0M $7.0M $19.0M $12.0M Borrowings $0 $0 $5.0M $5.0M $5.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-35.0M $-1.0M $-12.0M $-15.0M $-10.0M Investing Cash Flow $30.0M $29.0M $22.0M $-1.0M $0 Financing Cash Flow $0 $0 $0 $6.0M $-1.0M Net Cash Flow $-5.0M $-1.0M $5.0M $12.0M $-7.0M Free Cash Flow $-35.0M $-1.0M $-12.0M $-15.0M $-10.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.70 FCF Yield -11586.59% Quick Ratio 10.90 Interest Coverage -10643.00 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .